Leaflet PROTIONAMIDA ATB 250mg film-coated tablets

Product code:
W66101001
Quantity:
50
Indicated for:
tuberculosis
Route of administration:
oral
Substance:
protionamide (anti-tuberculosis agent)
ATC
J04AD01 — Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Thiocarbamide derivatives

Precautions:

Major drug interactions

This medicine may have important interactions with other medicines.

Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Pregnancy warning

Use during pregnancy only on medical advice.

Prothionamide is a medication used in the treatment of drug-resistant tuberculosis and other infections caused by mycobacteria. It works by inhibiting the synthesis of mycolic acids, which are essential for the bacterial cell wall.

The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important to adhere to the treatment regimen to prevent the development of bacterial resistance.

Side effects may include nausea, vomiting, abdominal pain, or liver disturbances. In rare cases, severe allergic reactions or psychiatric disorders may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as liver diseases, to ensure the safe use of prothionamide.

General data about PROTIONAMIDA ATB 250mg

Substance:
protionamide
Date of latest medicines list:
01-08-2019
Product code:
W66101001
Concentration:
250mg
Pharmaceutical form:
film-coated tablets
Quantity:
50
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
ANTIBIOTICE S.A. - ROMANIA
Holder:
ANTIBIOTICE S.A. - ROMANIA
Number:
11848/2019/01
Shelf life:
5 years

Pharmaceutical forms available for protionamide